Actively Recruiting
A Multicenter Clinical Trial to Confirm Home-based Upper Limb Rehabilitation Using Neofect Smart Board Compared to Conventional Therapy for Late Subacute and Chronic Brain Disorder Patients
Led by Samsung Medical Center · Updated on 2026-04-24
40
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating the clinical effectiveness, ease of use, and safety of a home-based upper limb rehabilitation program using the Neofect Smart Board. The study compares this approach to traditional home-based occupational therapy in patients with upper limb dysfunction due to neurological diseases in the late subacute and chronic stages. Participants include adults aged 19 to 85 who have hemiparesis from conditions like stroke, traumatic brain injury, or brain tumor, lasting more than three months. The trial has two groups: one uses the Neofect Smart Board device for rehabilitation, and the other uses a workbook provided by the research team for occupational therapy. Both groups complete 20 sessions, each lasting 30 minutes, with one session per day, five days a week, over four weeks. The study is randomized and single-blinded to compare the two rehabilitation methods fairly. Participants will be assessed on their upper limb function using the Fugl-Meyer assessment before and after the intervention. Researchers will monitor muscle strength, spasticity, cognitive function, and ability to perform tasks. Safety and usability of the device will also be observed. The total participation time includes the four-week training period with assessments conducted within two days after the intervention and up to 14 days before it.
CONDITIONS
Brief Title
Effect of Untact Upper Extremity Rehabilitation Using a Smart Board for Late Subacute and Chronic Patients With Brain Disorder
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with neurological diseases aged 19 to 85 years old
- Patients with hemiparesis lasting for more than 3 months due to neurological diseases such as stroke, traumatic brain injury, or brain tumor
- Patients with shoulder flexor and adductor muscle strength of MRC grade 2 or higher
- Patients with shoulder extensor and abductor spasticity of MAS grade 1+ or lower
- Participants with sufficient cognitive function to understand instructions and perform tasks (K-MMSE 61)
You will not qualify if you...
- Pre-existing significant neurogenic disorders
- Major psychiatric disorders such as schizophrenia, bipolar disorder, or dementia
- History of diseases causing pain or muscle atrophy in the affected upper limb before neurological disease onset, interfering with rehabilitation
- Severe spasticity of the affected upper limb (Modified Ashworth Scale score 63)
- Skin disorders or open wounds on the affected upper limb
- Amputation, fractures, or soft tissue-related diseases or injuries on the affected upper limb
- Severe pain interfering with rehabilitation of the affected upper limb (Numeric Rating Scale > 6)
- Inability to maintain a seated posture for more than 10 minutes
- Significant visual impairment preventing recognition of the smart board screen
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks
Participants undergo home-based upper limb rehabilitation training using either the Neofect Smart board or a workbook provided by the research team.
20 sessions, 30 minutes each, 1 session per day, 5 days a week
Trial Site Locations
Total: 1 location
1
Samsung medical center
Seoul, South Korea
Actively Recruiting
Research Team
W
Won Hyuk Chang
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here